Alpha 2.0
Login Register
» Articles » PMID: 6927282

Pharmacokinetics of the Cephalosporin SM-1652 in Mice, Rats, Rabbits, Dogs, and Rhesus Monkeys

Overview
Journal Antimicrob Agents Chemother
Publisher American Society for Microbiology
Specialty Pharmacology
Date 1982 Aug 1
PMID 6927282
Citations 19
Authors
H Matsui
K Yano
T Okuda
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetics of SM-1652 were studied in mice, rats, rabbits, dogs, and rhesus monkeys. The plasma half-lives of SM-1652, administered intravenously at a dose of 20 mg/kg, were 11.0 min in mice, 26.0 min in rats, 65.8 min in rabbits, 72.6 min in dogs, and 150.9 min in monkeys. The 24-h urinary excretion of SM-1652 was 30 to 35% of the dose in mice and rats, 70 to 75% in rabbits and dogs, and 45% in monkeys. Biliary excretion of the antibiotic over a 24-h period was 60 and 19% in rats and rabbits, respectively; it was 19% in dogs over a 9-h period after SM-1652 administration. Approximately 95% of the intravenous dose of SM-1652 was recovered as the unchanged form in the urine and bile of rats and rabbits. The binding of SM-1652 to serum protein was 44.0% in mice, 46.0% in rats, 90.4% in rabbits, 93.2% in monkeys, 30.0% in dogs, and 96.3% in humans.

Citing Articles

An in vivo role of Mrp2 in the rat hepatocytes by immunocytochemistry for amoxicillin using the transporter-deficient EHBR.

Fujiwara K, Shin M, Yoshizaki Y, Miyazaki T, Saita T J Mol Histol. 2012; 43(3):371-8.

PMID: 22446938 DOI: 10.1007/s10735-012-9406-2.

Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats.

Fujiwara K, Shin M, Miyazaki T, Maruta Y Antimicrob Agents Chemother. 2010; 55(1):62-71.

PMID: 20974868 PMC: 3019652. DOI: 10.1128/AAC.01031-10.

Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics.

Nakakariya M, Shimada T, Irokawa M, Koibuchi H, Iwanaga T, Yabuuchi H Pharm Res. 2007; 25(3):578-85.

PMID: 17891554 DOI: 10.1007/s11095-007-9427-9.

Quantitative evaluation of capacity-limited hepatobiliary transport based on hepatocellular diffusion model by MULTI(FEM).

Higashimori M, Yamaoka K, Fujitani S, Nakagawa T J Pharmacokinet Pharmacodyn. 2002; 28(5):415-44.

PMID: 11768289 DOI: 10.1023/a:1012206330281.

Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1.

Uchino H, Tamai I, Yabuuchi H, China K, Miyamoto K, Takeda E Antimicrob Agents Chemother. 2000; 44(3):574-7.

PMID: 10681320 PMC: 89728. DOI: 10.1128/AAC.44.3.574-577.2000.

References
1.
Nakai Y, Kanai Y, Fugono T, TANAYAMA S . Metabolic fate of cephacetrile after parenteral administration in rats and rabbits. J Antibiot (Tokyo). 1976; 29(1):81-90. DOI: 10.7164/antibiotics.29.81. View
2.
CABANA B, Van Harken D, Hottendorf G . Comparative pharmacokinetics and metabolism of cephapirin in laboratory animals and humans. Antimicrob Agents Chemother. 1976; 10(2):307-17. PMC: 429740. DOI: 10.1128/AAC.10.2.307. View
3.
Actor P, Uri J, Zajac I, GUARINI J, Phillips L, PITKIN D . SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. Antimicrob Agents Chemother. 1978; 13(5):784-90. PMC: 352331. DOI: 10.1128/AAC.13.5.784. View
4.
Lee C, HERR Jr E, Anderson R . Pharmacological and toxicological studies on cephalotin. Clin Med (Northfield). 1963; 70:1123-38. View
5.
Murakawa T, Sakamoto H, Fukada S, Nakamoto S, Hirose T, Itoh N . Pharmacokinetics of ceftizoxime in animals after parenteral dosing. Antimicrob Agents Chemother. 1980; 17(2):157-64. PMC: 283751. DOI: 10.1128/AAC.17.2.157. View